Daily Stock Analysis, BSX, Boston Scientific Corp, priceseries

Boston Scientific Corp. Daily Stock Analysis
Stock Information
Open
25.51
Close
25.27
High
25.58
Low
25.26
Previous Close
25.39
Daily Price Gain
-0.12
YTD High
25.65
YTD High Date
Feb 15, 2017
YTD Low
21.66
YTD Low Date
Jan 3, 2017
YTD Price Change
3.39
YTD Gain
15.47%
52 Week High
25.65
52 Week High Date
Feb 15, 2017
52 Week Low
16.82
52 Week Low Date
Mar 1, 2016
52 Week Price Change
8.00
52 Week Gain
46.38%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 29. 2016
18.55
May 19. 2016
22.17
37 Trading Days
19.52%
Link
LONG
Jan 3. 2017
21.88
Jan 26. 2017
23.52
16 Trading Days
7.49%
Link
Company Information
Stock Symbol
BSX
Exchange
NYSE
Company URL
http://www.bostonscientific.com
Company Phone
508-683-4000
CEO
Michael F. Mahoney
Headquarters
Massachusetts
Business Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA 01752-1234
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0000885725
About

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg.

Description

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.